Schond L. Greenway Avalo Therapeutics, Inc. (AVTX) insider trading activity

AVTX Quotes by TradingView

Schond L. Greenway is CFO of Avalo Therapeutics, Inc.. Currently has a direct ownership of 3,883 shares of AVTX, which is worth approximately $49,935. The most recent transaction as insider was on Dec 10, 2021, when has been sold 2,231 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $3,503. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.88K
0% 3M change
0% 12M change
Total Value Held $49,935

Schond L. Greenway Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2021
BUY
Open market or private purchase
$3,503 $1.57 p/Share
2,231 Added 36.49%
3,883 Common Stock
Jun 10 2021
BUY
Open market or private purchase
$1,747 $2.68 p/Share
652 Added 28.3%
1,652 Common Stock

Also insider at

MNMD
Mind Medicine (MindMed) Inc. Healthcare
Chief Financial Officer
SLG

Schond L. Greenway

CFO
Rockville, MD

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTX